SMAP1
Stromal membrane-associated protein 1
Also known as: FLJ13159, SMAP-1, SMAP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYB5
- Gene
- SMAP1
- Ensembl
- ENSG00000112305
- Chromosome
- 6
- Canonical length
- 467 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is similar to the mouse stromal membrane-associated protein-1. This similarity suggests that this human gene product is also a type II membrane glycoprotein involved in the erythropoietic stimulatory activity of stromal cells. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
467 residues, UniProt reviewed canonical sequence.
>Q8IYB5|SMAP1
1 MATRSCREKA QKLNEQHQLI LSKLLREEDN KYCADCEAKG PRWASWNIGV FICIRCAGIH
61 RNLGVHISRV KSVNLDQWTA EQIQCMQDMG NTKARLLYEA NLPENFRRPQ TDQAVEFFIR
121 DKYEKKKYYD KNAIAITNIS SSDAPLQPLV SSPSLQAAVD KNKLEKEKEK KKEEKKREKE
181 PEKPAKPLTA EKLQKKDQQL EPKKSTSPKK AAEPTVDLLG LDGPAVAPVT NGNTTVPPLN
241 DDLDIFGPMI SNPLPATVMP PAQGTPSAPA AATLSTVTSG DLDLFTEQTT KSEEVAKKQL
301 SKDSILSLYG TGTIQQQSTP GVFMGPTNIP FTSQAPAAFQ GFPSMGVPVP AAPGLIGNVM
361 GQSPSMMVGM PMPNGFMGNA QTGVMPLPQN VVGPQGGMVG QMGAPQSKFG LPQAQQPQWS
421 LSQMNQQMAG MSISSATPTA GFGQPSSTTA GWSGSSSGQT LSTQLWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 35 nTPM
- skeletal muscle: 32 nTPM
- testis: 30 nTPM
- parathyroid gland: 27 nTPM
- esophagus: 27 nTPM
- rectum: 27 nTPM
Single-cell type
- esophageal apical cells: 497 nCPM
- late spermatids: 367 nCPM
- early spermatids: 364 nCPM
- esophageal suprabasal cells: 343 nCPM
- innate lymphoid cells: 258 nCPM
- oocytes: 258 nCPM
Immune cell
- basophil: 35 nTPM
- NK-cell: 26 nTPM
- T-reg: 25 nTPM
- memory CD4 T-cell: 24 nTPM
- total PBMC: 23 nTPM
- neutrophil: 23 nTPM
Brain region
- cerebral cortex: 88 nTPM
- white matter: 58 nTPM
- hippocampal formation: 54 nTPM
- midbrain: 52 nTPM
- basal ganglia: 51 nTPM
- hypothalamus: 50 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SMAP1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 73 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMAP1 as an antibody target. Whether an autoantibody or antibody against SMAP1 could matter depends on whether native SMAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMAP1 is annotated at the cell surface, where native SMAP1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SMAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...